<DOC>
	<DOCNO>NCT01648764</DOCNO>
	<brief_summary>The purpose study evaluate two different dose regimen LY2334737 participant cancer advance and/or spread part body . Information side effect collect .</brief_summary>
	<brief_title>A Study LY2334737 Participants With Cancer That Advanced and/or Has Spread</brief_title>
	<detailed_description>This study consist Dose Escalation Phase ( Arms A B ) follow Dose Confirmation Phase .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Deoxyuridine</mesh_term>
	<criteria>Diagnosis advance and/or metastatic cancer ( include lymphoma ) treatment high priority exist Eastern Cooperative Oncology Group ( ECOG ) performance status â‰¤ 2 Estimated life expectancy 12 week Have discontinue previous therapy cancer least 30 day ( 6 week mitomycinC nitrosoureas ) recover acute effect therapy Have discontinue radiotherapy one week enrol study recover acute affect therapy Have adequate organ function Follow doctor 's direction live close enough study site continue go clinic followup Are willing able swallow capsule follow study procedure Have give write informed consent prior studyspecific procedure Males female reproductive potential use medically approve contraceptive precaution study 6 month follow last dose study drug Females childbearing potential must negative urine serum pregnancy test 7 day prior first dose study drug Have gastrointestinal disease prior surgery may interfere absorption medication take mouth Females pregnant lactate Symptomatic central nervous system malignancy metastasis Known positive test result human immunodeficiency virus ( HIV ) , hepatitis B surface antigen ( HBSAg ) , hepatitis C antibody ( HCAb ) Liver cirrhoses chronic hepatitis Acute chronic leukemia Are currently receive treatment valproic acid ( VPA ) 's derivative , history intolerance VPA Known hypersensitivity gemcitabine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>